Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0255 Transporter Info | ||||
Gene Name | SLC2A13 | ||||
Transporter Name | Proton myo-inositol cotransporter | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg02634414) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 4.82E-04; Z-score: 6.97E-01 | ||
Methylation in Case |
3.93E-01 (Median) | Methylation in Control | 3.19E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg15141217) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.52E-02; Z-score: 7.41E-01 | ||
Methylation in Case |
7.10E-01 (Median) | Methylation in Control | 6.84E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg27320127) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 7.05E-12; Z-score: 1.97E+00 | ||
Methylation in Case |
3.26E-01 (Median) | Methylation in Control | 2.61E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg19698309) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 3.62E-02; Z-score: -6.73E-01 | ||
Methylation in Case |
6.59E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg07788437) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 1.84E-05; Z-score: 1.34E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 6.76E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg24333621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.24E-03; Z-score: -6.68E-01 | ||
Methylation in Case |
8.31E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg24850535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 1.41E-03; Z-score: -1.05E+00 | ||
Methylation in Case |
3.35E-01 (Median) | Methylation in Control | 4.07E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg03479705) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.62E-03; Z-score: -3.73E-01 | ||
Methylation in Case |
4.02E-01 (Median) | Methylation in Control | 4.20E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC2A13 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
3'UTR (cg20558112) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 2.71E-04; Z-score: 1.29E+00 | ||
Methylation in Case |
6.65E-01 (Median) | Methylation in Control | 6.03E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg05581394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.72E+00 | Statistic Test | p-value: 4.48E-09; Z-score: -7.53E+00 | ||
Methylation in Case |
4.22E-01 (Median) | Methylation in Control | 7.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg01603095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.70E+00 | Statistic Test | p-value: 6.33E-03; Z-score: -3.46E+00 | ||
Methylation in Case |
1.51E-01 (Median) | Methylation in Control | 2.56E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg16219968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 4.06E-02; Z-score: -6.07E-01 | ||
Methylation in Case |
4.54E-02 (Median) | Methylation in Control | 4.80E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg05770947) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 3.39E-08; Z-score: -1.30E+01 | ||
Methylation in Case |
6.86E-01 (Median) | Methylation in Control | 8.99E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg21803141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 4.09E-08; Z-score: -6.47E+00 | ||
Methylation in Case |
4.90E-01 (Median) | Methylation in Control | 5.86E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14061497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 5.90E-08; Z-score: -1.11E+01 | ||
Methylation in Case |
7.34E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14678680) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 2.18E-06; Z-score: -1.12E+01 | ||
Methylation in Case |
6.95E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg02641941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.20E+00 | Statistic Test | p-value: 2.63E-06; Z-score: -5.74E+00 | ||
Methylation in Case |
2.79E-01 (Median) | Methylation in Control | 6.14E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg16190510) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.41E+00 | Statistic Test | p-value: 1.53E-05; Z-score: -5.09E+00 | ||
Methylation in Case |
2.12E-01 (Median) | Methylation in Control | 5.09E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg23680411) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.22E-03; Z-score: -2.33E+00 | ||
Methylation in Case |
8.57E-01 (Median) | Methylation in Control | 8.86E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg07287345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 5.19E-03; Z-score: -1.48E+00 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 9.02E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC2A13 in bladder cancer | [ 2 ] | |||
Location |
Body (cg04626413) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.10E-02; Z-score: -2.30E+00 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 9.15E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg01603095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.52E+00 | Statistic Test | p-value: 1.71E-09; Z-score: 2.62E+00 | ||
Methylation in Case |
3.13E-01 (Median) | Methylation in Control | 2.06E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg05581394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 8.21E-03; Z-score: 1.51E+00 | ||
Methylation in Case |
6.55E-01 (Median) | Methylation in Control | 5.74E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg14061497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 9.05E-12; Z-score: -2.14E+00 | ||
Methylation in Case |
8.05E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg14678680) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 2.46E-06; Z-score: 1.52E+00 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 7.15E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg21803141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 5.47E-04; Z-score: -8.99E-01 | ||
Methylation in Case |
5.88E-01 (Median) | Methylation in Control | 6.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg05770947) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.45E-03; Z-score: -4.33E-01 | ||
Methylation in Case |
8.58E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg07287345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.42E-03; Z-score: -6.78E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 9.03E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg02641941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 6.63E-03; Z-score: 4.40E-01 | ||
Methylation in Case |
7.61E-01 (Median) | Methylation in Control | 7.32E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC2A13 in breast cancer | [ 3 ] | |||
Location |
Body (cg00790847) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.40E-03; Z-score: -6.31E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.96E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg05581394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.79E-03; Z-score: -1.56E+00 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 9.32E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg01603095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 1.38E-02; Z-score: 9.37E-01 | ||
Methylation in Case |
3.23E-01 (Median) | Methylation in Control | 2.76E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg16219968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 4.26E-02; Z-score: -2.53E-01 | ||
Methylation in Case |
1.59E-02 (Median) | Methylation in Control | 1.68E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg05581394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 7.65E-10; Z-score: -2.35E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg04575343) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.06E-02; Z-score: 3.97E-01 | ||
Methylation in Case |
8.21E-02 (Median) | Methylation in Control | 7.79E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg05770947) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 1.38E-06; Z-score: -1.23E+00 | ||
Methylation in Case |
8.33E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg00790847) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 2.20E-05; Z-score: 1.42E+00 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 8.34E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg21803141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 4.90E-05; Z-score: -1.42E+00 | ||
Methylation in Case |
6.80E-01 (Median) | Methylation in Control | 7.26E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg02641941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.92E-02; Z-score: 9.64E-01 | ||
Methylation in Case |
6.40E-01 (Median) | Methylation in Control | 5.31E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg18785532) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.01E-02; Z-score: 6.23E-01 | ||
Methylation in Case |
9.18E-01 (Median) | Methylation in Control | 9.03E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC2A13 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg14061497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.57E-02; Z-score: -5.80E-01 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg02371464) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.86E+00 | Statistic Test | p-value: 1.10E-12; Z-score: 4.74E+00 | ||
Methylation in Case |
3.82E-01 (Median) | Methylation in Control | 2.05E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg01603095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 3.41E-04; Z-score: -7.89E-01 | ||
Methylation in Case |
2.82E-01 (Median) | Methylation in Control | 3.26E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg05581394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.42E-04; Z-score: -3.86E-01 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.41E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg14061497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 4.96E-07; Z-score: -1.02E+00 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg02641941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 4.66E-05; Z-score: 1.01E+00 | ||
Methylation in Case |
7.76E-01 (Median) | Methylation in Control | 7.19E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg05770947) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 1.06E-04; Z-score: -8.95E-01 | ||
Methylation in Case |
6.82E-01 (Median) | Methylation in Control | 7.53E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC2A13 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg16190510) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.98E-02; Z-score: -4.72E-01 | ||
Methylation in Case |
6.47E-01 (Median) | Methylation in Control | 6.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg01603095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 3.71E-04; Z-score: 2.53E+00 | ||
Methylation in Case |
4.51E-01 (Median) | Methylation in Control | 3.57E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg14061497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.37E-04; Z-score: -2.65E+00 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.96E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg16190510) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 2.15E-02; Z-score: 1.79E+00 | ||
Methylation in Case |
7.63E-01 (Median) | Methylation in Control | 6.96E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg05581394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 7.09E-03; Z-score: 5.11E-01 | ||
Methylation in Case |
2.79E+00 (Median) | Methylation in Control | 2.67E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in panic disorder | [ 8 ] | |||
Location |
Body (cg04626413) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.34E+00 | Statistic Test | p-value: 1.15E-08; Z-score: -1.16E+00 | ||
Methylation in Case |
3.78E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in panic disorder | [ 8 ] | |||
Location |
Body (cg00790847) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 9.68E-03; Z-score: 6.35E-01 | ||
Methylation in Case |
2.83E+00 (Median) | Methylation in Control | 2.68E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg16219968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 4.77E-04; Z-score: -1.43E+00 | ||
Methylation in Case |
5.60E-02 (Median) | Methylation in Control | 7.91E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg25307593) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 1.89E-05; Z-score: -5.48E-01 | ||
Methylation in Case |
4.24E-02 (Median) | Methylation in Control | 5.15E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg14061497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.70E-07; Z-score: -8.82E-01 | ||
Methylation in Case |
9.35E-01 (Median) | Methylation in Control | 9.46E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC2A13 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg04626413) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 8.72E-03; Z-score: -3.95E-01 | ||
Methylation in Case |
9.38E-01 (Median) | Methylation in Control | 9.43E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC2A13 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg02641941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.08E-02; Z-score: -4.10E-01 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in colon adenocarcinoma | [ 10 ] | |||
Location |
Body (cg04804543) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 3.16E-04; Z-score: -3.52E+00 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in colon adenocarcinoma | [ 10 ] | |||
Location |
Body (cg21491340) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.10E-03; Z-score: -4.44E+00 | ||
Methylation in Case |
9.21E-01 (Median) | Methylation in Control | 9.65E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC2A13 in prostate cancer | [ 11 ] | |||
Location |
Body (cg15999077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 1.74E-02; Z-score: -2.25E+00 | ||
Methylation in Case |
6.48E-01 (Median) | Methylation in Control | 7.64E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC2A13 in prostate cancer | [ 11 ] | |||
Location |
Body (cg15089806) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 3.16E-02; Z-score: 1.58E+00 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC2A13 in prostate cancer | [ 11 ] | |||
Location |
3'UTR (cg17442852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 9.19E-04; Z-score: 3.95E+00 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 6.26E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
17 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-1207 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1207 | miRNA Mature ID | miR-1207-5p | ||
miRNA Sequence |
UGGCAGGGAGGCUGGGAGGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-1910 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1910 | miRNA Mature ID | miR-1910-3p | ||
miRNA Sequence |
GAGGCAGAAGCAGGAUGACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-2682 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-2682 | miRNA Mature ID | miR-2682-5p | ||
miRNA Sequence |
CAGGCAGUGACUGUUCAGACGUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-335 directly targets SLC2A13 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-34b directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-34b | miRNA Mature ID | miR-34b-5p | ||
miRNA Sequence |
UAGGCAGUGUCAUUAGCUGAUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-381 directly targets SLC2A13 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-381 | miRNA Mature ID | miR-381-3p | ||
miRNA Sequence |
UAUACAAGGGCAAGCUCUCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
miR-4270 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4270 | miRNA Mature ID | miR-4270 | ||
miRNA Sequence |
UCAGGGAGUCAGGGGAGGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-4441 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4441 | miRNA Mature ID | miR-4441 | ||
miRNA Sequence |
ACAGGGAGGAGAUUGUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-449c directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-449c | miRNA Mature ID | miR-449c-5p | ||
miRNA Sequence |
UAGGCAGUGUAUUGCUAGCGGCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-4705 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4705 | miRNA Mature ID | miR-4705 | ||
miRNA Sequence |
UCAAUCACUUGGUAAUUGCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-4763 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4763 | miRNA Mature ID | miR-4763-3p | ||
miRNA Sequence |
AGGCAGGGGCUGGUGCUGGGCGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-6511a directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6511a | miRNA Mature ID | miR-6511a-5p | ||
miRNA Sequence |
CAGGCAGAAGUGGGGCUGACAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-6754 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6754 | miRNA Mature ID | miR-6754-5p | ||
miRNA Sequence |
CCAGGGAGGCUGGUUUGGAGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-6808 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6808 | miRNA Mature ID | miR-6808-5p | ||
miRNA Sequence |
CAGGCAGGGAGGUGGGACCAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 15 |
miR-6826 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6826 | miRNA Mature ID | miR-6826-5p | ||
miRNA Sequence |
UCAAUAGGAAAGAGGUGGGACCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-6893 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6893 | miRNA Mature ID | miR-6893-5p | ||
miRNA Sequence |
CAGGCAGGUGUAGGGUGGAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 17 |
miR-940 directly targets SLC2A13 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-940 | miRNA Mature ID | miR-940 | ||
miRNA Sequence |
AAGGCAGGGCCCCCGCUCCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.